Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)A Clinical Study of Intravenous Immunoglobulin
Phase 3
Completed
- Conditions
- Immunologic Deficiency Syndromes
- Interventions
- Drug: Immune Globulin Intravenous (Human) Omr-IgG-am IGIV
- First Posted Date
- 2007-05-02
- Last Posted Date
- 2014-08-11
- Lead Sponsor
- FFF Enterprises
- Target Recruit Count
- 57
- Registration Number
- NCT00468273
- Locations
- 🇺🇸
Mattel Children's Hospital of UCLA, Los Angeles, California, United States
🇺🇸1st Allergy and Clinical Research Center, Centennial, Colorado, United States
🇺🇸Allergy Associates of the Palm Beaches, North Palm Beach, Florida, United States
News
No news found